somnio 1.1.3

What is somnio?
Somnio is the first digital health application approved as an "app on prescription" specifically designed for patients with sleep disorders, particularly insomnia. It has undergone rigorous evaluation by the Federal Institute for Drugs and Medical Devices, securing its status as a Digital Health Application (DiGA).

How can I access somnio?
Somnio can be prescribed by any physician or psychotherapist equipped to issue health insurance prescriptions. Patients with a formal diagnosis of insomnia may also request access directly from their health insurance provider. To activate your account, a license code is necessary, which can be obtained from your health insurance company following the submission of the prescription or diagnosis confirmation. The application comes at no cost to users as it is covered by all statutory and some private health insurers. Detailed instructions for obtaining your access code are available at www.somn.io.

How does somnio function?
Somnio utilizes effective treatment methodologies to facilitate improved sleep patterns. The German Sleep Society advocates for cognitive behavioral therapy for insomnia (KVT-I), which forms the backbone of somnio's content. Users can expect to engage with various resources, including:

• Intelligent sleep diary maintenance
• Optimization of sleep schedules
• Strategies for managing intrusive thoughts and ruminations
• Targeted relaxation techniques
• Tracking individual sleep goals
• Optional integration with fitness trackers for enhanced sleep analysis

The application features Albert, a digital sleep expert powered by a sophisticated algorithm developed by sleep researchers. Users will progress through multiple modules where Albert provides insights into enhancing sleep quality through targeted questions and important educational content.

Clinical evidence of effectiveness
The efficacy of somnio has been demonstrated in a randomized controlled trial, revealing that users experienced a 50% reduction in insomnia symptoms. Notably, users also reported significant improvements in nighttime wakefulness, with these benefits persisting after 12 months. Key findings from the study are summarized as follows:

• 50% reduction in insomnia symptoms
• 18 minutes quicker time to fall asleep
• 31 minutes reduced time spent awake at night
• 25% increase in daytime functioning

As a certified Digital Health Application, somnio adheres to the highest standards of security and privacy.

For more detailed information regarding the product, please visit https://somn.io.

If you have further inquiries, do not hesitate to contact us at support@mementor.de; we are here to assist you.

*Somnio is certified as a CE Class 1 medical device in accordance with the Medical Device Directive (MDD).